Early-Onset Parkinson Disease Screening in Patients From Nigeria

Early-Onset Parkinson Disease Screening in Patients From Nigeria

Introduction: Nigeria is one of the most populated countries in the world; however, there is a scarcity of studies in patients with age-related neurodegenerative diseases, such as Parkinson disease (PD). The aim of this study was to screen patients with PD including a small cohort of early-onset PD...

Full description

Bibliographic Details
Main Authors:	Lukasz M. Milanowski, Olajumoke Oshinaike, Benjamin J. Broadway, Jennifer A. Lindemann, Alexandra I. Soto-Beasley, Ronald L. Walton, Rana Hanna Al-Shaikh, Audrey J. Strongosky, Fabienne C. Fiesel, Owen A. Ross, Wolfdieter Springer, Shamsideen Abayomi Ogun, Zbigniew K. Wszolek
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Neurology
Subjects:	Nigerian population MLPA Sanger sequencing LRRK2 PRKN PINK1
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2020.594927/full

Similar Items

Systematic Functional Analysis of <i>PINK1</i> and <i>PRKN</i> Coding Variants
by: Benjamin J. Broadway, et al.
Published: (2022-08-01)

Genotype-driven therapeutic developments in Parkinson’s disease
by: Jannik Prasuhn, et al.
Published: (2021-04-01)

The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity
by: Maya Ando, et al.
Published: (2017-04-01)

Identification and structural characterization of small molecule inhibitors of PINK1
by: Shafqat Rasool, et al.
Published: (2024-04-01)

Genetics of Parkinson´s disease: Recessive forms
by: P.A. Salles, et al.
Published: (2024-04-01)

Detection of Del/Dup Inside <i>SHOX</i>/PAR1 Region in Children and Young Adults with Idiopathic Short Stature
by: Jera Stritar, et al.
Published: (2021-09-01)

SHOX Variations in Idiopathic Short Stature in North India and a Review of Cases from Asian Countries
by: Priyanka Srivastava, et al.
Published: (2024-03-01)

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis.
by: Nicolas eDzamko, et al.
Published: (2014-06-01)

In Silico Investigation of Parkin-Activating Mutations Using Simulations and Network Modeling
by: Naeyma N. Islam, et al.
Published: (2024-03-01)

Parkin and its molecular associations in gliomas – a systematic review
by: Eduardo Morais de Castro, et al.
Published: (2021-05-01)

Case report: Early-onset Parkinson's disease with initial spastic paraparesis and hyperreflexia caused by compound heterozygous PRKN-gene exon 2 and 4 deletions
by: Ida Jensen, et al.
Published: (2022-11-01)

Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin.
by: Thomas R Caulfield, et al.
Published: (2014-11-01)

Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
by: Francesco Cavallieri, et al.
Published: (2023-02-01)

MTFP1 is a mitophagy receptor that operates in PINK1/PRKN-dependent mitophagy and promotes oral cancer cell survival
by: Debasna P Panigrahi, et al.
Published: (2023-12-01)

PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival
by: Yunjong Lee, et al.
Published: (2017-01-01)

Structural imaging in the presymptomatic stage of genetically determined parkinsonism
by: Kathrin Reetz, et al.
Published: (2010-09-01)

Pattern, risk factors, and outcome of acute stroke in a Nigerian university teaching hospital: A 1-year review
by: Babawale Arabambi, et al.
Published: (2021-01-01)

Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
by: Jae-Hyeon Park, et al.
Published: (2020-01-01)

Multi-tracer PET correlation analysis reveals disease-specific patterns in Parkinson’s disease and asymptomatic LRRK2 pathogenic variant carriers compared to healthy controls
by: Julia G. Mannheim, et al.
Published: (2024-01-01)

Molecular chaperones and Parkinson's disease
by: Shenglan Hu, et al.
Published: (2021-12-01)

Valosin-containing-protein pathogenic variant p.R487H in Parkinson’s disease
by: Capucine Piat, et al.
Published: (2024-01-01)

Prenatal diagnosis of 1408 foetuses at risk of DMD/BMD by MLPA and Sanger sequencing combined with STR linkage analysis
by: Chunxiao Hua, et al.
Published: (2023-12-01)

Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson’s disease
by: Paweł Turski, et al.
Published: (2022-09-01)

A homozygous PRKN-associated juvenile Parkinson's disease with pregnancy in China
by: Hong-xing Li, et al.
Published: (2023-02-01)

Comprehensive analysis of non-synonymous SNPs related to Parkinson’s disease and molecular dynamics simulation of PRKN mutants
by: Sapna Pandey, et al.
Published: (2023-01-01)

Parkin coregulates glutathione metabolism in adult mammalian brain
by: Daniel N. El Kodsi, et al.
Published: (2023-01-01)

Sequencing data and MLPA analysis data in support of the effectiveness and reliability of an asymmetric PCR-Based approach in preparing long MLPA probes
by: Xingyuan Ling, et al.
Published: (2015-09-01)

Maternally inherited Leigh syndrome detected by Multiplex ligation-dependent probe amplification
by: Lía Mayorga, et al.
Published: (2019-01-01)

Reduced ER-mitochondrial contact sites and mitochondrial Ca2+ flux in PRKN-mutant patient tyrosine hydroxylase reporter iPSC lines
by: Mutsumi Yokota, et al.
Published: (2023-09-01)

Large Intronic Deletion of the Fragile Site Gene PRKN Dramatically Lowers Its Fragility Without Impacting Gene Expression
by: Sebastian H. N. Munk, et al.
Published: (2021-07-01)

Molecular analysis of cyclin D1 modulators PRKN and FBX4 as candidate tumor suppressors in sporadic parathyroid adenomas
by: Kelly Brewer, et al.
Published: (2021-04-01)

Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation
by: Michael Aagaard Andersen, et al.
Published: (2018-08-01)

“Pretty in Pink”—The Pink Color in Architecture and the Built Environment: Symbolism, Traditions, and Contemporary Applications
by: Justyna Tarajko-Kowalska, et al.
Published: (2023-07-01)

Effects of Telmisartan, an AT1 receptor antagonist, on mitochondria-specific genes expression in a mouse MPTP model of Parkinsonism
by: Bipul Ray, et al.
Published: (2021-08-01)

PRKN regulates inner mitochondrial membrane PHB2 during mitophagy
by: Shan Sun, et al.
Published: (2023-12-01)

Prevalence of Nucleotide Alterations of EGFR Gene in Patients with Esophageal Squamous Cell Carcinoma in Kerman
by: M.R Lashkarizadeh, et al.
Published: (2012-07-01)

Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
by: Lukasz M. Milanowski, et al.
Published: (2022-06-01)

Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDG
by: Anna N. Ligezka, et al.
Published: (2023-08-01)

Constitutional and somatic methylation status of DMRH19 and KvDMR in Wilms tumor patients
by: Leila C.A. Cardoso, et al.
Published: (2012-01-01)

DMD/BMD prenatal diagnosis and treatment expectation in a single centre in China for 15 years
by: Xingjian Zhong, et al.
Published: (2021-07-01)